News from QAdvis

Strengthening QAdvis management roles with COO, CSO and CMO

To meet the increased demand of our services QAdvis has expanded its business significantly the last years. We have in December in addition formalized three management roles. Chief Operation Officer: Emma Axelsson. This includes the role as Deputy CEO Chief Sales Officer: Per Sundström Chief Medical Officer: Cecilia Emanuelsson In our new Edinburgh based office […]

Season´s Greatings! And best wishes for the New Year!

Even this year QAdvis refrain from Christmas gifts and choose to contribute to better health by supporting a major foundation. Every day a child is diagnosed with cancer. But there is hope. More children than ever survive their cancer today. We are proud to contribute to @Barncancerfonden during Christmas 2020! Read our Diploma (Swedish). Link […]

Welcome Irene Sebastianutto and Patricia Marmol!

We are very glad to welcome two new consultants to our team. Irene Sebastianutto PhD, native Italian, is based in our Lund office and Patricia Marmol PhD, native Spanish, is based in Stockholm. With these new fantastic colleagues, we are strengthening our clinical team and further increasing our international platform. Read more about our clinical […]

QAdvis congratulate EXINI Diagnostics AB for achieving their MDR-certificate

QAdvis want to congratulate one of our customers, EXINI Diagnostics AB, for achieving their MDR-certificate with help from our highly skilled consultants. The transfer to MDR and IVDR is getting closer to certification for many medical device manufacturers, We are proud that we can be part of that journey for several customers, guiding as well […]

United Kingdom Responsible Person

We are delighted to offer our professional services and to support you with successful post-Brexit clearance in the United Kingdom. In relation to the ongoing Brexit process, the regulatory landscape for medical devices and in-vitro diagnostic devices in the UK is significantly changing. Current guidance from Medicines and Healthcare products Regulatory Agency (MHRA) requires non-United […]